Efficacy of IV Acetaminophen in Acute Post-Operative Pain Control in Laparoscopic Roux-en-Y Gastric Bypass Surgery (LRYGBP) Patients

Status:Unknown status
Conditions:Obesity Weight Loss, Post-Surgical Pain
Therapuetic Areas:Endocrinology, Musculoskeletal
Age Range:18 - 65
Start Date:October 2011
Contact:Christina Lee, B.Sc.

Use our guide to learn which trials are right for you!

A Randomized, Double-Blind, Placebo-Controlled, Single Center Study of IV Acetaminophen for the Treatment of Post-Operative Pain After Laparoscopic Roux-en-Y Gastric Bypass Surgery (LRYGBP)

Laparoscopic Roux-en-Y gastric bypass (LRYGBP) is a common type of surgery in which length of
stay and morbidity is intimately associated with post-operative nausea and vomiting (PONV)
and recovery of bowel function. Medications most commonly used to control for post-operative
pain are opioid medications, whose well known adverse effects include PONV. Currently, no
studied adequate alternative to opiates exists for mild-moderate pain relief without the
aforementioned risks.

The primary goal for this study is to evaluate the the administration of pre- and
post-operative IV acetaminophen to determine if there is in an overall decrease in the use of
opioid analgesics by patient controlled analgesia (PCA) and subsequent decrease in subjective
PONV leading to sooner return of bowel function, enabling progression to oral intake and
decrease in post-operative length of stay.

Opioid use during the post-operative period is a highly effective means of treatment for
acute pain, however not without its adverse effects including post-operative nausea, vomiting
(PONV), constipation, urinary retention, sedation and respiratory depression. Such factors
have been implied in the literature to contribute to prolonged post-operative length of stay,
delayed return to diet, return of bowel function and increased incidence of ileus.
Alternatively, non-opioids, such as acetaminophen, aspirin, NSAIDs, and selective
cyclo-oxygenase-2 inhibitors, can be utilized for acute pain, either alone or in combination
with opioids. In the bariatric post-surgical population, NSAIDS both oral and IV (Toradol,
Ibuprofen) are not recommended due to their potential bleeding tendency, anti-inflammatory
effect, and ulcerogenic effect.

The LRYGBP may be classified as a surgery type associated with mild to moderate
post-operative pain. Therefore, the mode of pain relief could directly affect the length of
stay. The advent of IV acetaminophen serves as a opportunity to investigate in detail the
efficacy of this non-opioid medication in the management of acute pain in the immediate
post-operative period without the aforementioned adverse effects as expected from traditional
opiate medications. A comprehensive approach to this study includes a prospective,
double-blinded, randomized controlled trial of subjects who will undergo LRYGBP and
randomized to the study agent (IV acetaminophen) or placebo.

Inclusion Criteria:

- patients who are scheduled to undergo laparoscopic Roux-en-Y gastric bypass surgery
(LRYGBP) under general anesthesia.

- age 18 to 65 years

- BMI >35

- ASA scores 1,2, or 3

- a negative pregnancy test for female subjects of childbearing age

- ability to read, understand and provide informed consent to the study procedures

- ability to read and understand the use of pain and nausea scales (VAS)

Exclusion Criteria:

- known hypersensitivity to acetaminophen or opioids

- use of opioid or schedule II medications prior to commencement of the study >7 days

- those with chronic pain conditions or significant medical disease requiring pain

- abnormal liver function (aspartate aminotransferase/alanine aminotransferase/bilirubin
> 3X upper limit of normal range, active hepatic disease, clinically significant liver
disease, cirrhosis or hepatitis)

- known or suspected alcohol, drug or opiate abuse or dependence; or participation in
other clinical study within 30 days of surgery.
We found this trial at
Flint, Michigan 48507
Phone: 517-505-4640
Flint, MI
Click here to add this to my saved trials